Angiomics is a start-up biopharmaceutical company with the mission of discovering drugs from medicinal plants. The focus will be on accelerating wound healing. At present, the $5 billion global wound care market consists mainly of products that, at best, only create environments conducive to healing. The future of the wound care market lies in the promise of products that go beyond facilitative wound repair and actively accelerate the healing process. Angiomics already possesses a patent-protected technology that accelerates a key step in wound healing. Founded by three PhD students at the Unversity of Coventry, Angiomics is determined to stay in the lead by employing cutting-edge technologies in the drug discivery process.

ArrayScreen will exploit 'microarray' or '2DNA Chip' technology and the information provided by the Human Genome Project to develop revolutionary diagnostic tests to predict a variety of medical conditions such as cardiovascular disease.

PBT hold the right to a novel technology that allow first trimester screening for foetal genetic diseases, such as Down's Syndrome, using a low-risk, low-cost blood test.

A fabless semiconductor company, BOPPHY Technologies will design, develop and market innovative digital integrated circuits for broadband communications over the existing electrical infrastructure. Broadband over powerlines (BOP) gives customers high-speed internet access through the existing power grid network and enables utility companies to add data services to their offering. By exploiting state of the art modulation and coding techniques, our implementation of the physical layer (PHY) will ease competition against other broadband services by increasing current data rates of cable and DSL by up to a factor of 10.

Cambfix is a business prospect that provides innovative, high quality medical devices for use in orthopaedic and trauma surgery. Every year there are 1.5 million ankle and wrist fractures, which costs the healthcare industry $3 billion. Over one third of these cases develop a complication during treatment. Cambfixs first generation products have a patentable technology that addresses these complications in their entirety and can thereby save the healthcare industry $800 million in ankle and wrist fractures alone. The product pipeline also includes fixators for other fractured bones, soft tissue corrections, paediatric, veterinary and military use. Our products are non-invasive, offer a superior mode of treatment and will reduce patient morbidity by decreasing complications to less than 1%.

To provide a software solution for in silico drug discovery and prediction of drug side effects. Ccnet exploit the explosion of post-genomic data produced by high-throughput technologies such as DNA microarrays and portein chips.

Apply the latest power electronic technologies to solar energy applications, to produce cost effective solar products for developed and developing countries.

EnvAls novel technology is capable of recycling 100% of the waste obtained from post consumer drink cartons (i.e. Tetra Paks). The process recovers clean aluminium that can be sold to the aluminium industry and generates oils and gases suitable for heat or electricity production. EnvAl will contribute to the sustainable development of society by generating profit and by reducing the amount of materials that are currently being landfilled. EnvAl is seeking the partnership of an early stage investor who will provide financial backing to finish building the first demonstration equipment, and then remain with the company to realise its full potential.

Future Vision will help companies protect themselves against weather-related risks using weather derivatives. The weather derivatives market is an $8 billion market it has shown explosive growth over the last three years, especially in the US. Next year it is expected to double this growth in Europe. Future Vision will meet its clients' requirements for weather risk management by delivering advanced software solutions and by providing value-added professional services. Given the constantly changing environment, Future Vision will continue looking after its clients' needs by developing new products.

GEO has developed a novel, in-situ testing technique applicable to several niche construction quality control (CQC testing market, estimated at over 35m pa) within the rapidly growing environmental industry.

Light Blue Optics (LBO) is a dynamic, privately-owned company, developing miniature projection systems.

LBO’s patented holographic laser projection technology delivers full colour, high-quality video images that remain in focus at all distances. The technology’s efficiency, small form factor, robustness and cost advantages make it ideally suited for deployment in multiple markets including automotive, digital signage and consumer electronics.

LBO is funded by a group of investors including 3i plc., Earlybird Ventures and Capital-E.

A patentable solution to provide self-erecting scaffolding towers. Previously known as AccelErector.

To provide generic and efficient protein refolding technology to facilitate the production of recombinant proteins using bacteria hosts.

Owlstone introduces an innovative gas spectrometry technology shrinking the full functionality of conventional trace analysis instrumentation onto a chip.

To launch the next generation of frequency standard instruments modules providing an affordable solution in telecommunications, research and other high technology areas that require very accurate time on frequency standards.

Schmode's first product, the Light Tile, will make the surfaces of a room glow. As the technology develops, surfaces will change colour. Schmode will offer the first off-the-shelf electroluminescent product for designers or commercial and personal spaces.

Imagine a world with wireless power! Zap Wireless Technologies is developing a range of products (ZapPad, ZapCell, ZapDevices, ZapSystems) to replace disposable batteries and power cables in mobile phones, laptops and a range of other consumer and industrial applications. No disposable batteries, no wires, just ZAP! Founded by a team of three with outstanding expertise in wireless technologies, business and product innovation, Zap Wireless Technologies has built a prototype and is seeking first-round funding to support further R&D activities.

Collection and log-term storage of umbilical cord blood stem cells for the benefit of the newborn child and their family. Additional business activities will include viral screening and tissue-typing (genetic identification) of the colleced stem cells.

Tritech will leverage productivity from average users to business users by seamlessly integrating mobile communications with the computing world. This is done by providing a Platform for Ubiquitous Mobile Applications (PUMA) to support customised applications tailored towards different devices ranging from embeded devices to sophisticated devices supporting connectivity.

Weather Informatics provides bespoke forecast products, based on our proprietary WRIST package to enable weather-sensitive business to greatly improve their management of weather-related risks. Some 70% of all businesses, and as much as $1000bn of the US economy alone, are significantly exposed to take such risks. New financial products, 'weather derivatives', can be used by exposed bsuinesses to manage their risks. Over 4000 weather derivative contracts have been taken out thus far, with over $10bn in notional risk transferred. The customer-specific products taken out by Weather Informatics will give forecasts for use in the pricing of weather derivatives and will offer significant competitive advantage to our customers.